Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 49
Filter
2.
Trop Doct ; 50(2): 152-154, 2020 Apr.
Article in English | MEDLINE | ID: mdl-31937203

ABSTRACT

Black oesophagus, also termed acute oesophageal necrosis or Gurvits syndrome, is an uncommon but well-characterised entity predominantly involving the lower oesophagus. Co-morbidity-such as diabetes mellitus, hypertension, chronic liver or kidney or pulmonary disease-predisposes to this condition. On endoscopy, it appears as a diffuse, circumferential, black discolouration. Though poorly understood, tissue hypoperfusion appears central to its pathogenesis. Tackling the underlying predisposing co-morbidity and supportive management are the mainstay of therapy. Despite early diagnosis and prompt treatment, the outcome may be unfavourable and is related to the underlying aetiology. We report a case series of three patients of acute oesophageal necrosis who presented to us with symptoms of acute upper gastrointestinal bleeding and improved with conservative management.


Subject(s)
Esophageal Diseases/complications , Esophagus/pathology , Hematemesis/etiology , Acute Disease , Aged , Aged, 80 and over , Comorbidity , Endoscopy , Esophageal Diseases/diagnostic imaging , Esophageal Diseases/epidemiology , Esophageal Diseases/pathology , Esophagus/diagnostic imaging , Female , Hematemesis/diagnostic imaging , Hematemesis/epidemiology , Hematemesis/pathology , Humans , Male , Middle Aged , Necrosis
3.
Br J Radiol ; 93(1108): 20190637, 2020 Apr.
Article in English | MEDLINE | ID: mdl-31778313

ABSTRACT

OBJECTIVES: To retrospectively evaluate the safety and efficacy of transcatheter arterial embolization (TAE) for delayed arterial bleeding secondary to percutaneous self-expandable metallic stent (SEMS) placement in patients with malignant biliary obstruction (MBO). METHODS: From January 1997 to September 2017, 1858 patients underwent percutaneous SEMS placement for MBO at a single tertiary referral center. Among them, 19 patients (mean age, 70.2 [range, 52-82] years; 13 men) presented with delayed SEMS-associated arterial bleeding and underwent TAE. RESULTS: The incidence of delayed arterial bleeding was 1.0% (19/1858) after SEMS placement, with a median time interval of 225 days (range, 22-2296). Digital subtraction angiography (DSA) showed pseudoaneurysm alone close to the stent mesh (n = 10), pseudoaneurysm close to the stent mesh with contrast extravasation to the duodenum (n = 3), pseudoaneurysm close to the stent mesh with arteriobiliary fistula (n = 1), in-stent pseudoaneurysm alone (n = 4) and in-stent pseudoaneurysm with arteriobiliary fistula (n = 1). Bleeding was stopped after the embolization in all patients. Overall clinical success rate was 94.7% (18/19). One patient with recurrent bleeding was successfully treated with a second embolization. Overall 30-day mortality rate was 26.3% (5/19). A major procedure-related complication was acute hepatic failure in one hilar bile duct cancer patient (5.3%), which was associated with an obliterated portal vein. CONCLUSION: TAE is safe and effective for the treatment of delayed arterial bleeding after percutaneous SEMS placement for MBO. ADVANCES IN KNOWLEDGE: This study demonstrated TAE is safe and effective for arterial bleeding after SEMS placement after MBO through the largest case series so far.


Subject(s)
Aneurysm, False/therapy , Cholestasis/surgery , Embolization, Therapeutic/methods , Postoperative Hemorrhage/therapy , Self Expandable Metallic Stents/adverse effects , Aged , Aged, 80 and over , Aneurysm, False/diagnostic imaging , Angiography, Digital Subtraction , Biliary Fistula/diagnostic imaging , Biliary Fistula/therapy , Cholestasis/etiology , Embolization, Therapeutic/adverse effects , Female , Gastrointestinal Hemorrhage , Hematemesis/diagnostic imaging , Hematemesis/therapy , Hemobilia/diagnostic imaging , Hemobilia/therapy , Humans , Incidence , Male , Middle Aged , Postoperative Hemorrhage/epidemiology , Postoperative Hemorrhage/etiology , Prosthesis Implantation/adverse effects , Retrospective Studies , Vascular Fistula/diagnostic imaging , Vascular Fistula/therapy
4.
Rev Esp Enferm Dig ; 111(12): 961-962, 2019 12.
Article in English | MEDLINE | ID: mdl-31617363

ABSTRACT

Mucormycosis is a rare and fatal infection, largely confined to immunocompromised hosts. Duodenal involvement is extremely rare. We report a case of a 67-year-old female presented with hematemesis eventually diagnosed with duodenal mucormycosis, while radiology characteristics suggested malignancy.


Subject(s)
Duodenal Diseases/complications , Gastrointestinal Hemorrhage/etiology , Immunocompetence , Mucormycosis/complications , Aged , Diagnosis, Differential , Duodenal Diseases/diagnostic imaging , Duodenal Neoplasms/diagnostic imaging , Female , Gastrointestinal Hemorrhage/diagnostic imaging , Hematemesis/diagnostic imaging , Hematemesis/etiology , Humans , Mucormycosis/diagnostic imaging , Tomography, X-Ray Computed
5.
Indian J Gastroenterol ; 38(3): 190-202, 2019 06.
Article in English | MEDLINE | ID: mdl-31140049

ABSTRACT

BACKGROUND/PURPOSE OF THE STUDY: Acute upper gastrointestinal (UGI) bleed is a life-threatening emergency carrying risks of rebleed and mortality despite standard pharmacological and endoscopic management. We aimed to determine etiologies of acute UGI bleed in hospitalized patients and outcomes (rebleed rates, 5-day mortality, in-hospital mortality, 6-week mortality, need for surgery) and to determine predictors of rebleed and mortality. METHODS: Clinical and endoscopic findings were recorded in patients aged > 12 years who presented within 72 h of onset of UGI bleed. Outcomes were recorded during the hospital stay and 6 weeks after discharge. RESULTS: A total of 305 patients were included in this study, mean age being 44 ± 17 years. Most common etiology of UGI bleed was portal hypertension (62.3%) followed by peptic ulcer disease (PUD) (16.7%). Rebleed rate within 6 weeks was 37.4% (portal hypertension 47.9%, PUD 21.6%, malignancy 71.4%). Five-day mortality was 2.3% (malignancy 14.3%, portal hypertension 3.2%); the in-hospital mortality rate was 3.0% (malignancy 14.3%, portal hypertension 3.2%, PUD 0.0%) and 4.9% at 6 weeks (malignancy 28.6%, portal hypertension 5.8%, PUD 0.0%). Surgery was required in 4.59% patients. On multivariate analysis, post-endoscopy Rockall score was significantly predictive of rebleed in both portal hypertension- and PUD-related rebleed. No factors were found predictive of mortality in multivariate analysis. CONCLUSION: Portal hypertension remains the commonest cause of UGI bleed in India and carries a higher risk of rebleed and mortality as compared to PUD-related bleed. Post-endoscopy Rockall score is a useful tool for clinicians to assess risk of rebleed.


Subject(s)
Hematemesis/etiology , Hematemesis/mortality , Hypertension, Portal/complications , Melena/etiology , Melena/mortality , Neoplasms/complications , Acute Disease , Adolescent , Adult , Aged , Endoscopy, Gastrointestinal , Esophageal and Gastric Varices/complications , Female , Gastric Antral Vascular Ectasia/complications , Hematemesis/diagnostic imaging , Hematemesis/surgery , Hospital Mortality , Humans , India/epidemiology , Liver Cirrhosis/complications , Male , Melena/diagnosis , Melena/surgery , Middle Aged , Peptic Ulcer Hemorrhage/diagnostic imaging , Peptic Ulcer Hemorrhage/mortality , Peptic Ulcer Hemorrhage/surgery , Recurrence , Tertiary Care Centers , Young Adult
16.
J Radiol Case Rep ; 7(2): 1-10, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23705034

ABSTRACT

Intramural esophageal hematoma is part of a spectrum of esophageal injuries. Vomiting and straining, endoscopic procedures and bleeding disorders are the most common predisposing factors. However, it can also be an unusual complication of anticoagulation and/or thrombolysis therapy. The most common symptoms are retrosternal chest pain, dysphagia and hematemesis. Computed tomography is the modality of choice and treatment is medically conservative with the cessation of Warfarin and thrombolysis use. When anticoagulation and/or thrombolysis therapy is necessary, periodic reassessment for symptoms of intramural esophageal hematoma may be helpful for early identification and management. We described one case of intramural esophageal hematoma possibly resulting from anticoagulation and/or thrombolysis therapy in the setting of pulmonary embolism.


Subject(s)
Anticoagulants/adverse effects , Esophageal Diseases/etiology , Hematoma/etiology , Pulmonary Embolism/complications , Thrombolytic Therapy/adverse effects , Warfarin/adverse effects , Aged , Anticoagulants/administration & dosage , Chest Pain/diagnostic imaging , Chest Pain/etiology , Deglutition Disorders/diagnostic imaging , Deglutition Disorders/etiology , Diagnosis, Differential , Esophageal Diseases/diagnostic imaging , Esophageal Diseases/mortality , Esophageal Diseases/therapy , Fatal Outcome , Hematemesis/diagnostic imaging , Hematemesis/etiology , Hematoma/diagnostic imaging , Hematoma/mortality , Hematoma/therapy , Humans , Male , Pulmonary Embolism/diagnostic imaging , Pulmonary Embolism/mortality , Pulmonary Embolism/therapy , Tomography, X-Ray Computed , Warfarin/administration & dosage
18.
Ann Thorac Surg ; 94(3): 1010-1, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22916758

ABSTRACT

The presence of an aberrant right subclavian artery represents a potentially risky situation when high mediastinal surgery is planned. We report a case of a patient needing transhiatal esophagectomy for cancer; the presence of the abnormal anatomic arterial situation complicated the postoperative course, when a vascular- digestive fistula appears. We discuss the direct causes and consequences of a rare situation.


Subject(s)
Carcinoma, Squamous Cell/surgery , Esophageal Fistula/etiology , Esophageal Neoplasms/surgery , Esophagectomy/adverse effects , Esophagectomy/methods , Subclavian Artery/abnormalities , Vascular Fistula/etiology , Aged , Carcinoma, Squamous Cell/pathology , Diaphragm/surgery , Emergencies , Esophageal Fistula/surgery , Esophageal Neoplasms/pathology , Fatal Outcome , Hematemesis/diagnostic imaging , Hematemesis/etiology , Hematemesis/surgery , Hemostasis, Surgical/methods , Humans , Male , Mediastinoscopy/methods , Neoplasm Invasiveness , Neoplasm Staging , Postoperative Complications/diagnostic imaging , Postoperative Complications/surgery , Preoperative Care/methods , Reoperation , Risk Assessment , Tomography, X-Ray Computed/methods , Vascular Fistula/surgery
19.
Clin Nucl Med ; 36(11): 987-90, 2011 Nov.
Article in English | MEDLINE | ID: mdl-21975385

ABSTRACT

A 6-month pregnant 35-year-old woman with hematemesis and dark blood in her stool was evaluated for location of an active gastrointestinal bleeding site. The findings from 2 esophagogastroduodenoscopies and a colonoscopy were negative. The patient was referred for a Tc-99m red blood cell scintigraphy, for location of an active bleeding site. As the patient was 6 months pregnant, the necessity of the case was discussed with the patient's referring physician and after determining that this study was necessary, the risk of radiation exposure to the fetus was discussed with the radiation safety officer and the patient. The procedure was performed after the patient signed informed consent regarding the considerations of radiation safety to the fetus. The Tc-99m red blood cell bleeding scan clearly shows activity in the fetus in addition to a large arteriovenous malformation in the patient. The visualized fetus prompted this report to discuss radiation risks concerns and a brief review of indications and guidelines for performing nuclear medicine procedures in pregnant patients.


Subject(s)
Erythrocytes/diagnostic imaging , Hematemesis/complications , Hematemesis/diagnostic imaging , Hemorrhage/complications , Hemorrhage/diagnostic imaging , Practice Guidelines as Topic , Technetium , Adult , Arteriovenous Malformations/complications , Arteriovenous Malformations/diagnostic imaging , Female , Humans , Pregnancy , Radionuclide Imaging
20.
Radiologe ; 51(6): 514-7, 2011 Jun.
Article in German | MEDLINE | ID: mdl-21512762

ABSTRACT

A 42-year-old female patient presented with acute pain of the upper abdomen, postprandial vomiting and hematemesis. An operation for gastric banding had been carried out 1 month prior to presentation. The abdominal X-ray and radioscopy revealed a posterior slippage of the gastric fundus following the gastric banding operation.


Subject(s)
Abdominal Pain/etiology , Foreign-Body Migration/etiology , Gastroplasty/adverse effects , Hematemesis/etiology , Vomiting/etiology , Abdominal Pain/diagnostic imaging , Diagnosis, Differential , Female , Foreign-Body Migration/diagnostic imaging , Gastroplasty/instrumentation , Hematemesis/diagnostic imaging , Humans , Radiography , Vomiting/diagnosis
SELECTION OF CITATIONS
SEARCH DETAIL
...